Clinical trial
A Single-Center Phase I/II Study Of Peg-Encapsulated Islet Allografts Implanted In Patients With Type I Diabetes
NCT00260234 is registered in ClinicalTrials.gov with Novocell as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-Center Phase I/II Study Of Peg-Encapsulated Islet Allografts Implanted In Patients With Type I Diabetes
- Lead sponsor
- Novocell
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- November 30, 2005
- Completion date
- December 31, 2007
- Enrollment
- 12
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.